Portfolio (Quarterly)
Guide ↗
PSP Research LLC
· CIK 0002106939| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 16,000.0 | $613K | 0.43% | -6K | -26.8% | $38.30 | -12.8% |
| 2 | — | ASCENDIS PHARMA A/S | — | 2,500.0 | $572K | 0.41% | -79.0 | -3.1% | $228.73 | — |
| 3 | PHVS | PHARVARIS N V | Healthcare | 20,000.0 | $565K | 0.40% | -511.0 | -2.5% | $28.25 | +4.2% |
| 4 | RPRX | ROYALTY PHARMA PLC | Healthcare | 11,000.0 | $528K | 0.37% | -3K | -20.4% | $47.97 | +10.6% |
| 5 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 6,300.0 | $525K | 0.37% | -48.0 | -0.8% | $83.29 | -3.2% |
| 6 | INCY | INCYTE CORP | Healthcare | 5,300.0 | $499K | 0.35% | -50.0 | -0.9% | $94.12 | +3.5% |
| 7 | — | PRAXIS PRECISION MEDICINES I | — | 1,500.0 | $483K | 0.34% | -482.0 | -24.3% | $322.19 | — |
| 8 | IMVT | IMMUNOVANT INC | Healthcare | 19,200.0 | $477K | 0.34% | -1K | -5.4% | $24.84 | +37.4% |
| 9 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 20,000.0 | $467K | 0.33% | -5K | -19.1% | $23.36 | -13.8% |
| 10 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 5,000.0 | $462K | 0.33% | -2K | -27.1% | $92.38 | +9.0% |
| 11 | COGT | COGENT BIOSCIENCES INC | Healthcare | 12,000.0 | $462K | 0.33% | -1K | -9.3% | $38.49 | -15.4% |
| 12 | CRSP | CRISPR THERAPEUTICS AG | Healthcare | 9,500.0 | $452K | 0.32% | -80.0 | -0.8% | $47.57 | +4.9% |
| 13 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 6,000.0 | $446K | 0.32% | -1K | -16.0% | $74.26 | -5.4% |
| 14 | AUPH | AURINIA PHARMACEUTICALS INC | Healthcare | 30,000.0 | $445K | 0.32% | -4K | -11.6% | $14.82 | +4.3% |
| 15 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 14,000.0 | $438K | 0.31% | -4K | -20.0% | $31.29 | +14.2% |
| 16 | IMNM | IMMUNOME INC | Healthcare | 20,000.0 | $437K | 0.31% | -5K | -20.8% | $21.87 | +5.0% |
| 17 | — | KINIKSA PHARMACEUTICALS INTL | — | 9,000.0 | $433K | 0.31% | -4K | -28.9% | $48.15 | — |
| 18 | TGTX | TG THERAPEUTICS INC | Healthcare | 13,000.0 | $432K | 0.31% | -5K | -27.0% | $33.22 | +19.7% |
| 19 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 5,000.0 | $420K | 0.30% | -8K | -60.7% | $83.92 | +6.8% |
| 20 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 13,000.0 | $412K | 0.29% | -7K | -36.2% | $31.72 | -3.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%